Select Medical Holdings (SEM) Misses Q2 EPS by 1c; reaffirms guidance

Select Medical Holdings (NYSE: SEM) reported Q2 EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.74 billion.

GUIDANCE:

Select Medical Holdings sees FY2024 EPS of $1.96-$2.20, versus the consensus of $2.12. Select Medical Holdings sees FY2024 revenue of $6.9-7.1 billion, versus the consensus of $7.005 billion.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Starts Nippon Life India Asset Management Ltd (NAM:IN) at Overweight
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings